Researchers discover another reason for the naked mole rats' long, cancer-free life

February 09, 2018

A new international study has identified clues concerning the cellular processes that contribute to the naked mole rat's resistance to cancer.

Cancer is rife in the animal kingdom. For many, the mortality rate is similar or even higher to that suffered by humans.

Cancer occurs when a seemingly normal cell spirals out of control. Usually, damaged or defective cells are destroyed, but occasionally one will keep proliferating, creating more and more rogue cells. The eventual result is a tumour.

The more cells an organism has and the longer it lives, the more likely it is that one of its cells will succumb to a random cancer-causing mutation. However there are exceptions.

Natural defence mechanism

The naked mole rat (NMR) is an exceptionally long-lived and cancer-resistant rodent native to East Africa. NMRs have a natural defence mechanism against cancer. After several decades of observation, very few naked mole rats have been observed developing tumours.

In the new study an international collaboration of scientists, including researchers from the University of Liverpool's Institute of Ageing and Chronic Disease (IACD), studied NMRs to see if the rodents exhibit an anticancer mechanism called cellular senescence and, if so, how the mechanism might work differently than in short-lived animals, like mice.

Cellular senescence prevents damaged cells from dividing out of control and developing into cancer. However, by stopping cell division in order to prevent potential tumours, senescent cells can also accelerates aging.

Unique features 

Previous studies have found that when the cells that had undergone senescence were removed from mice, the mice were less weak in advanced age when compared to mice that aged naturally with senescent cells intact.

In order to prevent cancer, abnormal cells need to be prevented from dividing. However, to prevent aging cells need to keep dividing in order to replenish tissues.

The researchers compared the senescence response of NMRs to that of mice, which live a tenth as long. They found that although NMRs do experience cellular senescence they continue to live healthy, long lives.

The researchers found that although naked mole rats exhibited cellular senescence similar to mice, their senescent cells also displayed unique features that may contribute to their cancer resistance and longevity.

The study has been published in the Proceedings of the National Academy of Sciences of the USA (PNAS) journal.

'More resistant to DNA damage'

Dr Joao Pedro De Magalhaes, University of Liverpool's Institute of Ageing and Chronic Disease, said: "Our research suggests that naked mole rats are able to inhibit metabolic processes of the senescent cells, resulting in senescent cells that are less pathogenic.

"In addition, naked mole rat cells are more resistant to DNA damage. Therefore, one hypothesis is that the way naked mole rats are better able to cope with damage to their genome is essential for their longevity and cancer resistance."
-end-
The lead researchers for the study are from the University of Rochester (New York). Other collaborators include researchers from; Center for Data-Intensive Biomedicine and Biotechnology (Skolkovo), Institute of Science and Technology (Moscow), Brigham and Women's Hospital, Harvard Medical School (Boston), Spanish National Cancer Research Centre (Madrid), Cancer Research UK, University of Cambridge, Hutchison/MRC Research Centre (Cambridge), Barcelona Institute of Science and Technology, Catalan Institute of Advanced Studies (Barcelona) and the University of Haifa (Israel).

The research was supported by grants from the National Institute of Aging and by the Life Extensions Foundation.

The full study, entitled 'Naked mole rats can undergo developmental, oncogene-induced and DNA damage-induced cellular senescence', can be found here http://www.pnas.org/content/early/2018/01/30/1721160115

University of Liverpool

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.